Overall survival
The percentage of patients still alive after a set period — a key clinical trial endpoint.
What it is
Overall survival is a measure of how long patients with cancer live after starting treatment. It's calculated by looking at the number of people who are still alive after a certain period of time, usually several months or years. This helps doctors and researchers understand how well a treatment is working and whether it's improving survival rates.
How it works
In a clinical trial, overall survival is tracked by following patients over time. Researchers look at how many patients are still alive at certain points, such as 6 months, 1 year, or 5 years after starting treatment. This information is then used to compare the effectiveness of different treatments.
Why it matters
Understanding overall survival is important because it helps doctors and researchers make informed decisions about treatment options. It also gives patients and their families a better idea of what to expect from treatment and whether it's working. By tracking overall survival, researchers can identify the most effective treatments and make them more widely available.
This information is provided for general education only and is not medical advice. Always consult a qualified healthcare professional for guidance on your health.